Medical Treatments for Prostate CancerThere are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer. Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy - an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) - surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery - this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence. Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy. The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy's side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped. |
| anticancer cancer drug prostate sage |
|
Anti-Cancer Drugs - Fulltext: Volume 16(2) February 2005 p 201-210 Anti-Cancer Drugs:Volume 16(2)February 2005pp 201-210 of the PHSCN sequence and the antiangiogenic compound tetrathiomolybdate in prostate cancer. Development and Use of a High-Throughput Bacterial DNA Gyrase Boyd MR: The NCI in vitro anticancer drug discovery screen: concept, implementation and operation 1985-1995. In Teicher BA (ed): Cancer Drug Discovery and Sunlight--A Cancer Drug? -- Stokstad 2005 (202): 1 -- ScienceNOW For example, mortality from breast, prostate, and colon cancer tends to be in the skin after UV exposure--has anticancer effects on many kinds of cells. General Principles and Pharmacology of Antineoplastic Agents Drug Intell Clin Pharm 20:746-751, 1986Abstract; Leuprolide Study Group: Leuprolide versus diethylstilbestrol for metastatic prostate cancer. Cancer Weekly (2005-04-05) | NewsRx Cancer Drugs - Carbohydrate-geldanamycin conjugates synthesized into potent anticancer drug Cancer Drugs - Etodolac enhanced carboplatin-induced apoptosis The Sol Goldman Pancreatic Cancer Research Center: Advances and Activin receptors-A new anticancer signal in human tumors (June 2001): . A novel target for anti-biliary tract cancer drug development (January 2001): Everyday Cancer Drugs Some common drugs show new promise for cancer treatment. a 30% lower risk of breast cancer in postmenopausal women, a 58% lower risk of prostate cancer, Drug Discovery Today : SAGE and related approaches for cancer Subject-index terms: Pharmaceutical Science; Drug Discovery; Cancer biology; Chemical Biology. Article Outline. SAGE and related techniques Cancer Cell : Advancing the field of drug delivery: Taking aim at Liposome-mediated delivery of anticancer drugs has improved First endocrinological and pharmacokinetic data in patients with advanced prostate cancer. Anti-Cancer Drugs - Fulltext: Volume 18(3) March 2007 p 349-355 Anti-Cancer Drugs:Volume 18(3)March 2007pp 349-355 .. Visualization of advanced human prostate cancer lesions in living mice by a targeted gene transfer A Serial Analysis of Gene Expression (SAGE) Database Analysis of Furthermore, cell lines have been widely used in testing new anticancer agents, Cell Lines: Implications for Identifying Drug Resistance Genes in Cancer The American Institute for Cancer Research (AICR): Vitamin D and By uncovering one potential biological reason for the anti-cancer effects of . respectively) and also more than rats that took the prostate cancer drug Therapeutic drug monitoring of cancer chemotherapy -- Alnaim 13 (4 Clinical pharmacokinetics and pharmacodynamics of anticancer drugs in children. . to control plasma drug concentration in patients with prostate cancer. Polymer Doxorubicin Conjugate with a Synthetic Peptide Ligand The polymerâ”drug conjugate exhibits significant antiproliferative activity against human metastatic prostate cancer cell line PC3MM2 in vitro. Future Drugs - Expert Review of Anticancer Therapy - 5(1):63 Despite this regimen, prostate cancer invariably progresses to a fatal, (2005) Targeting CK2 for cancer therapy. Anti-Cancer Drugs 16:10, 1037 Future Directions for Research on Silybum marianum for Cancer A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients . Invest New Drugs. 2007;25: 139-146 . Effects of Homeopathic Preparations on Human Prostate Cancer Inhibition of growth and regulation of IGFs and VEGF in human prostate cancer cell lines by shikonin analogue 93/637 (SA). Anticancer Res. CANCER MODELS: Systems for Identifying New Drugs Are Often Faulty Contributions of human tumor xenografts to anticancer drug development. Intraosseous Growth and Invasiveness of PC-3 Human Prostate Cancer in Nude Mice. BIOTECHNOLOGY BUSINESS: On the Biotech Pharm, a Race to Harvest Science Magazine, Daily News, STKE, SAGE KE, Science Careers Of the world's eight top-selling anticancer drugs, four--the prostate cancer drugs Casodex, |
| anticancer cancer drug prostate sage |
|
gay prostate milking checking for prostate cancer chondroitin prostate cancer after prostate sex surgery |